Cover Image

The role of Traditional Chinese medicine in anti-HBV: background, progress, and challenges

Abstract Chronic hepatitis B (CHB) remains a major world's most serious public health issues. Despite the remarkable effect of nucleos(t)ide analogues (NAs) in inhibiting hepatitis B virus (HBV) deoxyribonucleic acid (DNA) as the first-line drug, there are several limitations still, such as poo...

Full description

Saved in:

Bibliographic Details
Main Authors:	Feilin Ge (Author), Yan Yang (Author), Zhaofang Bai (Author), Lanlan Si (Author), Xuemei Wang (Author), Jia Yu (Author), Xiaohe Xiao (Author), Yan Liu (Author), Zhigang Ren (Author)
Format:	Book
Published:	BMC, 2023-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
by: Fei-lin Ge, et al.
Published: (2021)

T cell--associated immunoregulation and antiviral effect of oxymatrine in hydrodynamic injection HBV mouse model
by: Xiuxiu Sang, et al.
Published: (2017)

Pharmacological effects of Chinese medicine modulating NLRP3 inflammasomes in fatty liver treatment
by: Tingting Liu, et al.
Published: (2022)

Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021)

The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
by: Cristina Stasi, et al.
Published: (2016)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
by: Si-Yu Yuan, et al.
Published: (2022)

The combination of Schisandrin C and Luteolin synergistically attenuates hepatitis B virus infection via repressing HBV replication and promoting cGAS-STING pathway activation in macrophages
by: Zhixin Wu, et al.
Published: (2024)

Research progress on antiviral constituents in traditional Chinese medicines and their mechanisms of action
by: Zhi Chen, et al.
Published: (2022)

A review on the research progress of traditional Chinese medicine with anti-cancer effect targeting ferroptosis
by: Longyan Wang, et al.
Published: (2023)

New progress in HBV control and the cascade of health care for people living with HBV in China: evidence from the fourth national serological survey, 2020Research in context
by: Zheng Hui, et al.
Published: (2024)

Research progress of treating hyperuricemia in rats and mice with traditional Chinese medicine
by: Haodong Bai, et al.
Published: (2024)

HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC)
by: Wenhui Wang, et al.
Published: (2022)

Research Progress of Traditional Chinese Medicine in Treatment of Myocardial fibrosis
by: Chunzhen Ren, et al.
Published: (2022)

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
by: Min You, et al.
Published: (2023)

Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population
by: Yan Zehui, et al.
Published: (2012)

A Modern Technology Applied in Traditional Chinese Medicine: Progress and Future of the Nanotechnology in TCM
by: Guojun Yan, et al.
Published: (2019)

Liver-Targeted Anti-HBV Single-Stranded Oligonucleotides with Locked Nucleic Acid Potently Reduce HBV Gene Expression In Vivo
by: Hassan Javanbakht, et al.
Published: (2018)

Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
by: Hua Zhong, et al.
Published: (2022)

Immunostimulatory activity and structure-activity relationship of epimedin B from Epimedium brevicornu Maxim.
by: Yuan Gao, et al.
Published: (2022)

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
by: Xiao-Zhen Kang, et al.
Published: (2018)

Molecular mechanism and research progress on pharmacology of traditional Chinese medicine in liver injury
by: Hong Yang Zhang, et al.
Published: (2018)

The Role and Mechanisms of Traditional Chinese Medicine for Airway Inflammation and Remodeling in Asthma: Overview and Progress
by: Bo-wen Zhou, et al.
Published: (2022)

Traditional Chinese medicine in COVID-19
by: Ming Lyu, et al.
Published: (2021)

Application of microcalorimetry of Escherichia coli growth and discriminant analysis to the quality assessment of a Chinese herbal injection (Yinzhihuang)
by: Yongshen Ren, et al.
Published: (2012)

Research progress of traditional Chinese medicine influencing macrophage polarization
by: Shuang GAO, et al.
Published: (2021)

Research progress on the ethanol precipitation process of traditional Chinese medicine
by: Yanni Tai, et al.
Published: (2020)

Seroprevalence of anti-HBc, risk factors of occupationally acquired HBV infection and HBV vaccination among hospital staff in Poland: a multicenter study
by: Maria Ganczak, et al.
Published: (2019)

Biomedical knowledge graph construction of Sus scrofa and its application in anti-PRRSV traditional Chinese medicine discovery
by: Mingyang Cui, et al.
Published: (2024)

Landscape of DILI-related adverse drug reaction in China Mainland
by: Jiabo Wang, et al.
Published: (2022)

Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
by: Lai Wei, et al.
Published: (2022)

Hyperuricemia research progress in model construction and traditional Chinese medicine interventions
by: Hongyan Zhou, et al.
Published: (2024)

Progress in Traditional Chinese Medicine Against Respiratory Viruses: A Review
by: Bao-Hong Li, et al.
Published: (2021)

Progress in the Mechanism of Autophagy and Traditional Chinese Medicine Herb Involved in Dementia
by: Pengyu Tao, et al.
Published: (2022)

Progress on Active Analgesic Components and Mechanisms of Commonly Used Traditional Chinese Medicines: A Comprehensive Review
by: Ruizhou Wang, et al.
Published: (2018)

Germacrone Attenuates Hepatic Stellate Cells Activation and Liver Fibrosis via Regulating Multiple Signaling Pathways
by: Zhiyong Li, et al.
Published: (2021)

Progress and challenges in integrated traditional Chinese and western medicine in China from 2002 to 2021
by: Man-Ci Zhou, et al.
Published: (2024)

Traditional chinese medicine in coronary microvascular disease
by: Zhihua Yang, et al.
Published: (2022)

Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression
by: Zheng Zeng, et al.
Published: (2021)

Self-assembled natural phytochemicals for synergistically antibacterial application from the enlightenment of traditional Chinese medicine combination
by: Xuehao Tian, et al.
Published: (2020)

A Polysaccharide From Eupolyphaga sinensis Walker With Anti-HBV Activities In Vitro and In Vivo
by: Xue Zhang, et al.
Published: (2022)